Rivaroxaban Evaluation in Real Life Settings "RIVER"


Phase N/A Results N/A

Summary of Purpose

To discover outcomes of patients treated with Rivaroxaban with atrial fibrillation with at least one additional investigator-determined risk factor for stroke in real-life practice.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 May 2015.

1 May 2015 12 May 2015 1 Dec 2018 1 Dec 2018 1 May 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample


Not available